Atlantic Trust Group LLC raised its position in shares of Monsanto (NYSE:MON) by 2,080.5% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 404,834 shares of the basic materials company’s stock after purchasing an additional 386,268 shares during the period. Atlantic Trust Group LLC owned approximately 0.09% of Monsanto worth $48,506,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in MON. Vanguard Group Inc. increased its holdings in shares of Monsanto by 2.6% in the second quarter. Vanguard Group Inc. now owns 30,725,725 shares of the basic materials company’s stock worth $3,636,697,000 after buying an additional 784,418 shares during the period. BlackRock Inc. increased its holdings in shares of Monsanto by 6.5% in the second quarter. BlackRock Inc. now owns 27,898,255 shares of the basic materials company’s stock worth $3,302,038,000 after buying an additional 1,705,439 shares during the period. State Street Corp increased its holdings in shares of Monsanto by 0.6% in the second quarter. State Street Corp now owns 20,276,780 shares of the basic materials company’s stock worth $2,399,965,000 after buying an additional 122,814 shares during the period. Capital International Investors increased its holdings in shares of Monsanto by 10.3% in the third quarter. Capital International Investors now owns 9,344,430 shares of the basic materials company’s stock worth $1,119,650,000 after buying an additional 872,377 shares during the period. Finally, Northern Trust Corp increased its holdings in shares of Monsanto by 0.7% in the second quarter. Northern Trust Corp now owns 7,092,929 shares of the basic materials company’s stock worth $839,519,000 after buying an additional 47,725 shares during the period. Institutional investors and hedge funds own 75.45% of the company’s stock.
Shares of Monsanto (MON) opened at $116.28 on Friday. The company has a current ratio of 1.35, a quick ratio of 0.83 and a debt-to-equity ratio of 1.12. The firm has a market capitalization of $50,829.89, a P/E ratio of 22.76, a price-to-earnings-growth ratio of 1.66 and a beta of 1.04. Monsanto has a 12-month low of $104.77 and a 12-month high of $122.79.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 26th. Shareholders of record on Friday, January 5th will be given a dividend of $0.54 per share. The ex-dividend date is Thursday, January 4th. This represents a $2.16 annualized dividend and a yield of 1.86%. Monsanto’s payout ratio is 42.27%.
In other news, COO Brett D. Begemann sold 22,640 shares of the business’s stock in a transaction that occurred on Monday, September 25th. The stock was sold at an average price of $120.03, for a total value of $2,717,479.20. Following the sale, the chief operating officer now directly owns 85,439 shares of the company’s stock, valued at approximately $10,255,243.17. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, CFO Pierre Courduroux sold 4,320 shares of the business’s stock in a transaction that occurred on Thursday, October 19th. The stock was sold at an average price of $122.00, for a total value of $527,040.00. Following the completion of the sale, the chief financial officer now directly owns 48,388 shares in the company, valued at $5,903,336. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 49,236 shares of company stock worth $5,931,934. Insiders own 0.79% of the company’s stock.
Several research analysts have recently commented on MON shares. Zacks Investment Research upgraded Monsanto from a “hold” rating to a “buy” rating and set a $131.00 price objective on the stock in a report on Monday, September 4th. BMO Capital Markets restated a “buy” rating and set a $128.00 price target on shares of Monsanto in a report on Friday, September 1st. Royal Bank of Canada restated a “hold” rating and set a $128.00 price target on shares of Monsanto in a report on Wednesday, November 15th. Jefferies Group restated a “hold” rating and set a $128.00 price target on shares of Monsanto in a report on Friday, September 15th. Finally, Macquarie downgraded Monsanto from an “outperform” rating to a “neutral” rating in a report on Wednesday, October 4th. Twelve analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus target price of $124.61.
Monsanto Company Profile
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto (NYSE:MON).
Receive News & Ratings for Monsanto Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto and related companies with MarketBeat.com's FREE daily email newsletter.